Download Full eBooks in PDF
Ahfs Drug Information 2002 Book in PDF, ePub and Kindle version is available to download in english. Read online anytime anywhere directly from your device. Click on the download button below to get a free pdf file of Ahfs Drug Information 2002 book. This book definitely worth reading, it is an incredibly well-written.
Author : American Society of Health-System Pharmacists
Publisher : Unknown
Page : 0 pages
File Size : 53,9 Mb
Release : 2002
Category : Clinical pharmacology
ISBN : 158528033X
Author : Gerald K. McEvoy
Publisher : Unknown
Page : 2296 pages
File Size : 49,8 Mb
Release : 2006
Category : Clinical pharmacology
ISBN : UOM:39015074270524
Author : Anonim
Publisher : Unknown
Page : 3772 pages
File Size : 47,6 Mb
Release : 2003
Category : Clinical pharmacology
ISBN : 9791585280390
Author : Gerald K. McEvoy
Publisher : Unknown
Page : 0 pages
File Size : 47,9 Mb
Release : 2004
Category : Clinical pharmacology
ISBN : 1585280585
Author : Gerald K. McEvoy,American Society of Health-System Pharmacists
Publisher : Unknown
Page : 1544 pages
File Size : 50,9 Mb
Release : 2004
Category : Medical
ISBN : 1585281034
Author : American Society of Health System Pharmacists,Ashp
Publisher : Unknown
Page : 840 pages
File Size : 49,8 Mb
Release : 2020
Category : Electronic
ISBN : 1585286117
Author : American Hospital Formulary Service
Publisher : Unknown
Page : 0 pages
File Size : 41,6 Mb
Release : 2009
Category : Medical
ISBN : 1585282278
Being truly prepared means having the only compendium of evidence-based drug information at hand. the go-to book in pharmacies for more than 50 years, AHFS Drug Information is your trusted source when you need unbiased answers to critical questions. the only drug information resource published by a professional scientific association, AHFS offers the highest level of quality and trust that a drug guide can provide and gives the most expert, authoritative analysis to guide clinical decisions.
Author : American Society of Health-System Pharmacists
Publisher : Unknown
Page : 0 pages
File Size : 41,8 Mb
Release : 2012
Category : Clinical pharmacology
ISBN : 1585282677
Annotation Written and published by pharmacists and reviewed by over 500 experts, AHFS Drug Informationr (AHFS DI) is the most comprehensive evidence-based source of drug information complete with therapeutic guidelines and off-label uses. The only print compendium designated by the US Congress, AHFS DI is also the only reference published by a professional and scientific society - ensuring it is the most authoritative and best-selling reference trusted by pharmacists for 55 years. 700,000 Adverse Drug Events occur every year. The majority of these are preventable. AHFS DI is a must-have resource to have at your fingertips. Its detailed and comprehensive drug monographs deliver valuable information and therapeutic guidelines to even the most complex questions. Don't waste time searching other references when you know you will always find the answer you can trust to be accurate inside-every time. Don't you owe it to yourself, your profession, and your patients? Inside find peer-reviewed monographs that cover: * Expanded and revised content, featuring critical new monograph updates every year * Interactions, adverse reactions, cautions, and more * Therapeutic recommendations supported by evidence from primary research * Preparations, chemistry, and stability * Pharmacology and pharmacokinetics * Prescription, OTC, ophthalmic and dermatologic drugs * Extensive, off-label uses and dosing options * Vaccines and other immunizing agents As always, there is a strong focus on safe and effective use of drugs. Hundreds of monographs have been updated for FDA's MedWatch alerts, risk evaluation mitigation strategies (REMS), and other critical safety information. Be sure to stay up to date with the latest medwatch alerts, new drug monographs, and updates, with your online access to AHFS Drug Information. Get access with the username and password found within the preface of the print book.
Author : Gerald K. McEvoy
Publisher : Unknown
Page : 3300 pages
File Size : 40,8 Mb
Release : 1999
Category : Drugs
ISBN : 1879907917
Author : AMERICAN SOCIETY OF HEALTH SYSTEM PHARMACISTS.
Publisher : Unknown
Page : 0 pages
File Size : 53,5 Mb
Release : 2024
Category : Clinical pharmacology
ISBN : 1585287210
Author : Gerald K. McEvoy
Publisher : Unknown
Page : 2800 pages
File Size : 47,7 Mb
Release : 1996-01-01
Category : Medicine
ISBN : 1879907615
Author : Gerald K. McEvoy
Publisher : Amer Soc of Health System
Page : 2900 pages
File Size : 43,8 Mb
Release : 1997-01-01
Category : Medical
ISBN : 1879907690
Author : Anonim
Publisher : Unknown
Page : 2604 pages
File Size : 48,8 Mb
Release : 2007-07-01
Category : Electronic
ISBN : 1585281824
Author : Anonim
Publisher : Unknown
Page : 2400 pages
File Size : 46,7 Mb
Release : 1990
Category : Electronic
ISBN : 0930530969
Author : ASHP,American Society of Health-System Pharmacists
Publisher : Unknown
Page : 0 pages
File Size : 51,7 Mb
Release : 2022-02-28
Category : Medical
ISBN : 1585286842
AHFS Drug Information® 2022 contains the most dependable drug information available-all in one place. It is the most comprehensive evidence-based source of drug information complete with therapeutic guidelines and off-label uses. With expanded and revised content supported by more than 97,000 references and incorporating the advice of numerous subject matter experts, AHFS DI helps you protect your patients and your practice. Updates in the new edition: The latest information on COVID-19 vaccines and COVID-19 monoclonal antibodies available under FDA Emergency Use Authorizations (EUAs), including clinical considerations from the US Centers for Disease Control and Prevention (CDC), and National Institutes of Health (NIH). Information on patient selection and appropriate use of corticosteroids in the management of COVID-19 based on recent guidelines from NIH and the World Health Organization (WHO). Contemporary issues such as anticoagulant reversal strategies and use of direct oral anticoagulants versus warfarin for treatment of venous thromboembolism or atrial fibrillation. Current best practices such as reversal of neuromuscular blocking agents for prevention of postoperative residual neuromuscular blockade. Newly published information on breakthrough oncology drugs approved as part of the FDA's accelerated approval program. Expanded content on off-label uses, real-world data, and long-term clinical data. Updated information on pharmacogenomic considerations based on recommendations from the Clinical Pharmacogenetics Implementation Consortium (CPIC). Addition of 51 new molecular entities (NMEs) or new therapeutic biological products approved since January 2021.
